LU72897A1 - - Google Patents

Info

Publication number
LU72897A1
LU72897A1 LU72897A LU72897A LU72897A1 LU 72897 A1 LU72897 A1 LU 72897A1 LU 72897 A LU72897 A LU 72897A LU 72897 A LU72897 A LU 72897A LU 72897 A1 LU72897 A1 LU 72897A1
Authority
LU
Luxembourg
Application number
LU72897A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed filed Critical
Publication of LU72897A1 publication Critical patent/LU72897A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
LU72897A 1974-07-05 1975-07-03 LU72897A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (1)

Publication Number Publication Date
LU72897A1 true LU72897A1 (cg-RX-API-DMAC7.html) 1976-05-31

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72897A LU72897A1 (cg-RX-API-DMAC7.html) 1974-07-05 1975-07-03

Country Status (14)

Country Link
JP (1) JPS5250800B2 (cg-RX-API-DMAC7.html)
AR (1) AR210330A1 (cg-RX-API-DMAC7.html)
AT (1) AT339917B (cg-RX-API-DMAC7.html)
CA (1) CA1062710A (cg-RX-API-DMAC7.html)
CH (2) CH622519A5 (cg-RX-API-DMAC7.html)
DK (1) DK140214B (cg-RX-API-DMAC7.html)
ES (1) ES439141A1 (cg-RX-API-DMAC7.html)
FI (1) FI59249C (cg-RX-API-DMAC7.html)
FR (1) FR2277089A1 (cg-RX-API-DMAC7.html)
GB (1) GB1500039A (cg-RX-API-DMAC7.html)
LU (1) LU72897A1 (cg-RX-API-DMAC7.html)
NL (1) NL166476C (cg-RX-API-DMAC7.html)
NO (1) NO143224C (cg-RX-API-DMAC7.html)
SE (2) SE420097B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
FI59249C (fi) 1981-07-10
JPS5250800B2 (cg-RX-API-DMAC7.html) 1977-12-27
FI751958A7 (cg-RX-API-DMAC7.html) 1976-01-06
JPS5134194A (cg-RX-API-DMAC7.html) 1976-03-23
ES439141A1 (es) 1977-02-16
NL7507976A (nl) 1976-01-07
DK301775A (cg-RX-API-DMAC7.html) 1976-01-06
DK140214C (cg-RX-API-DMAC7.html) 1979-12-03
NL166476B (nl) 1981-03-16
ATA517275A (de) 1977-03-15
NO752423L (cg-RX-API-DMAC7.html) 1976-01-06
AR210330A1 (es) 1977-07-29
AT339917B (de) 1977-11-10
SE420097B (sv) 1981-09-14
SE427183B (sv) 1983-03-14
CA1062710A (en) 1979-09-18
NL166476C (nl) 1981-08-17
CH622519A5 (en) 1981-04-15
AU8275575A (en) 1977-01-06
SE7507726L (sv) 1976-01-07
FR2277089B1 (cg-RX-API-DMAC7.html) 1978-03-17
CH622018A5 (en) 1981-03-13
NO143224B (no) 1980-09-22
DK140214B (da) 1979-07-09
SE7807853L (sv) 1978-07-14
FI59249B (fi) 1981-03-31
FR2277089A1 (fr) 1976-01-30
NO143224C (no) 1981-01-02
GB1500039A (en) 1978-02-08

Similar Documents

Publication Publication Date Title
DK141761C (cg-RX-API-DMAC7.html)
FR2277089B1 (cg-RX-API-DMAC7.html)
DK140092C (cg-RX-API-DMAC7.html)
DE2423112A1 (cg-RX-API-DMAC7.html)
CH584502A5 (cg-RX-API-DMAC7.html)
CH586856A5 (cg-RX-API-DMAC7.html)
DD111316A1 (cg-RX-API-DMAC7.html)
CH564977A5 (cg-RX-API-DMAC7.html)
CH570912A5 (cg-RX-API-DMAC7.html)
CH587005A5 (cg-RX-API-DMAC7.html)
CH587574A4 (cg-RX-API-DMAC7.html)
CH571272A5 (cg-RX-API-DMAC7.html)
CH571134A5 (cg-RX-API-DMAC7.html)
CH588652A5 (cg-RX-API-DMAC7.html)
CH577249A5 (cg-RX-API-DMAC7.html)
CH599495A5 (cg-RX-API-DMAC7.html)
BG20989A1 (cg-RX-API-DMAC7.html)
CH582876A5 (cg-RX-API-DMAC7.html)
BG20483A1 (cg-RX-API-DMAC7.html)
DD110754A5 (cg-RX-API-DMAC7.html)
CH583669A5 (cg-RX-API-DMAC7.html)
CH582339A5 (cg-RX-API-DMAC7.html)
CH575615B5 (cg-RX-API-DMAC7.html)
CH586829A5 (cg-RX-API-DMAC7.html)
CH596899A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee